e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Airway inflammation and asthma control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reversibility test may be another marker of asthma control
L. Melosini, F. L. Dente, M. Latorre, F. Novelli, E. Bacci, A. Di Franco, M. Carli, P. Paggiaro (Pisa, Italy)
Source:
Annual Congress 2009 - Airway inflammation and asthma control
Session:
Airway inflammation and asthma control
Session type:
Thematic Poster Session
Number:
3968
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Melosini, F. L. Dente, M. Latorre, F. Novelli, E. Bacci, A. Di Franco, M. Carli, P. Paggiaro (Pisa, Italy). Reversibility test may be another marker of asthma control. Eur Respir J 2009; 34: Suppl. 53, 3968
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Evaluation of asthma control test and correlation with objective measures of lung function and inflammation
Source: Eur Respir J 2007; 30: Suppl. 51, 367s
Year: 2007
Assessment of asthma status using the asthma control test in Indian patients
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Airway hyperresponsiveness to mannitol is an independent marker of asthma control and disease phenotype
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018
Comparative assessment of asthma control test and GINA classification in predicting asthma severity
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II
Year: 2007
Assessing the relative contribution of the asthma control testÔ (ACT) and spirometry in predicting asthma control
Source: Eur Respir J 2004; 24: Suppl. 48, 472s
Year: 2004
Control of allergic rhinitis and asthma test, asthma control test and FeNO in asthma
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012
Discrepancy of non-invasive inflammatory markers and lung function tests to current level of clinical control in childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Exercise test with dry air inhalation compared to mannitol test as marker of exercise induced asthma
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Comparison of usefulness of selected lung function tests in the diagnosis of exercise induced bronchoconstriction
Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases
Year: 2010
COPD assessment test correlation with the increase of the inflammatory markers in COPD exacerbations
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Relationship between asthma control test (ACT) and clinical, functional and inflammatory markers in treated and non treated asthmatics
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
Validity of asthma control test in Chinese patients
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II
Year: 2007
Features of COPD in correlation with COPD assessment test
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019
The effects of rhinitis and smoking on evaluating the asthma control with asthma control test (ACT), FEV
1
and FeNO
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008
Comparison of the asthma control test and % predicted FEV1 in relation to correlation with physicians assessment of asthma control and treatment decisions
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
Change of exercise challenge test and mannitol challenge test during optimized asthma treatment in adolescents with exercise induced asthma
Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children
Year: 2008
Using of the asthma control test for rating the level of the control over disease in Kyrgyzstan
Source: Eur Respir J 2007; 30: Suppl. 51, 767s
Year: 2007
Predictive factors of a positive methacholine challenge response based on data from a baseline respiratory function test
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Does presence of bronchoprovocation test positivity effect the development of allergic respiratory disease: 7 year follow-up study
Source: Annual Congress 2011 - Asthma: risk factors and comorbidities
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept